Leaders on the Front Line of a Global Pandemic
Hear how three Maryland companies -- Novavax, Maryland Tech Council, and The Biotechnology Innovation Organization -- worked together to expedite vaccine development during COVID-19, and how they are overcoming the business and scientific challenges that they encounter.
Phyllis Arthur - Vice President of Infectious Diseases and Diagnostics, Biotechnology Innovation Organization
Brian Rosen - Senior Vice President of Commercial Strategy, Novavax
Martin Rosendale - CEO, Maryland Tech Council